JET-MABS

Welcome to the Brand page for “JET-MABS”, which is offered here for Joining effector target multi-antigen biotherapeutics;research and development of therapeutic antibodies and pharmaceuticals, and research and development of technology in the field of therapeutic antibodies and pharmaceuticals;.

Its status is currently believed to be active. Its class is unavailable. “JET-MABS” is believed to be currently owned by “TENIUM THERAPEUTICS, INC.”


Owner:
TENIUM THERAPEUTICS, INC.
Owner Details
Description:
JOINING EFFECTOR TARGET MULTI-ANTIGEN BIOTHERAPEUTICS;Research and development of therapeutic antibodies and pharmaceuticals, and research and development of technology in the field of therapeutic antibodies and pharmaceuticals;
Categories: JOINING EFFECTOR TARGET MULTI ANTIGEN BIOTHERAPEUTICS